Back to GILD
Rhenman & Partners Asset Management AB → GILD
Rhenman & Partners Asset Management AB GILD Position History
Gilead Sciences, Inc. • Healthcare
Quarters held
4
Latest value
$23.7M
Q3 2026
Peak value
$23.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $15.5M |
| Q1 2026 | $23.4M |
| Q2 2026 | $22.5M |
| Q3 2026 | $23.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $23.7M | 159.1K | — | — |
| Q2 2026 | $22.5M | 178.3K | — | — |
| Q1 2026 | $23.4M | 167.8K | — | — |
| Q4 2025 | $15.5M | 126.2K | — | — |